Biotechnology Assets S.A. Cash Flow
Concept
Operating Cash Flow
Net Income
Depreciation & Amortization
Stock based compensation
Other non cash items
Change in working capital
Investing Cash Flow
Capital Expenditures
Financing Cash Flow
Dividends Paid
Payout Ratio
Share Issuance / Repurchase
Debt Issued / Paid
Other Investing Activities
End Cash Position
Changes in Cash
Beginning Cash Position
Free Cash Flow
2022
2021
2020
2019
-2M
-204M
215M
0M
3M
-15M
0M
212M
115M
59M
-28.91 %
-8M
0M
53M
69M
-99M
168M
-213M
-2M
-3M
2M
0M
0M
0M
0M
1M
3M
1M
-28.57 %
-1M
0M
3M
2M
1M
1M
-2M
9M
-8M
2M
0M
3M
12M
0M
0M
-58M
0M
-0 %
0M
0M
0M
1M
-4M
5M
8M
-15M
-10M
4M
0M
0M
-10M
0M
7M
23M
0M
-0 %
0M
0M
56M
5M
1M
4M
-23M
Concept
Operating Cash Flow
Net Income
Depreciation & Amortization
Stock based compensation
Other non cash items
Change in working capital
Investing Cash Flow
Capital Expenditures
Financing Cash Flow
Dividends Paid
Payout Ratio
Share Issuance / Repurchase
Debt Issued / Paid
Other Investing Activities
End Cash Position
Changes in Cash
Beginning Cash Position
Free Cash Flow